Occurrence of pre-S1 antigen in viremic and nonviremic carriers of hepatitis B surface antigen
- PMID: 2460586
- DOI: 10.1002/jmv.1890260213
Occurrence of pre-S1 antigen in viremic and nonviremic carriers of hepatitis B surface antigen
Abstract
The proteins of viral envelope, encoded by the pre-S1 region of HBV-DNA, were measured quantitatively with enzyme immunoassay using monoclonal antibodies directed to pre-S1 epitope and correlated with the expression of pre-S2 region encoded epitope and other HBV markers. In acute HBV infection, both pre-S encoded proteins were detected in sera along with markers of viral replication and disappeared shortly before complete virus clearance while high HBsAg titers were still present. Pre-S1 antigen was present in most (95.5%) symptomatic and asymptomatic chronic HBsAg carriers. There was no correlation between the presence of pre-S1 and HBeAg or HBV-DNA in serum: 73% of sera with pre-S1 determinants were anti-HBe positive, and only 25.4% were positive for HBV-DNA. Most pre-S1 activity in sera of viremic carriers was detected in fractions of sucrose gradient containing subviral 22-nm particles, and much less in those containing infectious virions. In asymptomatic, nonviremic HBsAg carriers, pre-S1 was located only on subviral 22-nm forms. Pre-S1 positive particles had no accessible pre-S2 epitope, which is recognized specifically by monoclonal anti-pre-S2 (F124) antibody. These results show that the synthesis of the large protein of HBV envelope may occur also in the absence of active viral replication, and in these cases pre-S1 encoded sequences are on subviral particles of HBsAg. Therefore, pre-S1 is not a serologic marker of infectious virus. Disappearance of pre-S1 epitopes on HBsAg occurs only before complete clearance of the virus, and this may have potential prognostic relevance.
Similar articles
-
New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection.J Clin Microbiol. 1992 May;30(5):1111-9. doi: 10.1128/jcm.30.5.1111-1119.1992. J Clin Microbiol. 1992. PMID: 1583107 Free PMC article.
-
Serum HBsAg, HBeAg, anti-HBe, and hepatitis B viral DNA in asymptomatic carriers in Taiwan.J Med Virol. 1986 May;19(1):87-94. doi: 10.1002/jmv.1890190113. J Med Virol. 1986. PMID: 3701304
-
Quantitative analysis of pre-S1 and pre-S2 in relation to HBsAg expression.Hepatology. 1990 Jan;11(1):38-43. doi: 10.1002/hep.1840110108. Hepatology. 1990. PMID: 2295469
-
Methods for the study of pre-S proteins of hepatitis B virus and their antibodies: pathogenetic and clinical implications.Ric Clin Lab. 1988 Apr-Sep;18(2-3):241-58. doi: 10.1007/BF02918887. Ric Clin Lab. 1988. PMID: 3062749 Review.
-
Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.Viruses. 2020 Jan 21;12(2):126. doi: 10.3390/v12020126. Viruses. 2020. PMID: 31973017 Free PMC article. Review.
Cited by
-
Nature and display of hepatitis B virus envelope proteins and the humoral immune response.Springer Semin Immunopathol. 1990;12(1):5-23. doi: 10.1007/BF00192678. Springer Semin Immunopathol. 1990. PMID: 1695029 Review. No abstract available.
-
Assay of preS epitopes and preS1 antibody in hepatitis B virus carriers and immune persons.Med Microbiol Immunol. 1990;179(1):49-60. doi: 10.1007/BF00190150. Med Microbiol Immunol. 1990. PMID: 1691815
-
Correlation of preS antigens and clinical status during chronic hepatitis B virus infection.Med Microbiol Immunol. 1991;180(5):239-48. doi: 10.1007/BF00202558. Med Microbiol Immunol. 1991. PMID: 1762604
-
New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection.J Clin Microbiol. 1992 May;30(5):1111-9. doi: 10.1128/jcm.30.5.1111-1119.1992. J Clin Microbiol. 1992. PMID: 1583107 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical